Page last updated: 2024-10-21

3-methoxytyrosine and Dyskinesia, Drug-Induced

3-methoxytyrosine has been researched along with Dyskinesia, Drug-Induced in 2 studies

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nutt, JG1
Carter, JH1
Woodward, W1
Hammerstad, JP1
Gancher, ST1
Luquin, MR1
Vaamonde, J1
Obeso, JA1

Other Studies

2 other studies available for 3-methoxytyrosine and Dyskinesia, Drug-Induced

ArticleYear
Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:2

    Topics: Aged; Carbidopa; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Tolerance;

1993
Levodopa and 3-O-methyldopa plasma levels in parkinsonian patients with stable and fluctuating motor response.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:1

    Topics: Aged; Carbidopa; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Di

1989